FADS1 and Crohn disease: This study enhances the findings in [16] regarding PUFA involvement by establishing that it is ω3 rather than ω6 fatty acids that are likely to be protective, and implicating FADS2 over FADS1 as the key enzyme in the small bowel specifically influencing Crohn’s disease risk.